Back to Journals » Hepatic Medicine: Evidence and Research » Volume 9

Economic impact of the use of rifaximin 550 mg twice daily for the treatment of overt hepatic encephalopathy in Italy

Total article views   HTML views PDF downloads Totals
9,265 Dovepress* 7,985+ 1,177 9,162
PubMed Central* 1,280 200 1,480
Totals 9,265 1,377 10,642
*Since 25 September 2017

View citations on PubMed Central and Google Scholar